| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +10.69% | +3.67% | +7.01% | +7.01% | — |
| 14d | 2 | +0.00% | +12.74% | +6.99% | +5.76% | +5.76% | — |
| 30d | 2 | +0.00% | +22.55% | +9.88% | +12.66% | +12.66% | — |
| 60d | 2 | +0.00% | +29.75% | — | — | — | — |
| 90d | 2 | +0.00% | +42.30% | +13.87% | +28.44% | +28.44% | — |
| 180d | 2(2 pending) | — | — | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PTHS PELTHOS THERAPEUTICS INC. | SALE10b5-1 10b5-1 plan | 280 | $21.36 | $6.0K | 27,422 | Apr 2, 2026 | Apr 6, 2026 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | SALE10b5-1 10b5-1 plan | 310 | $20.51 | $6.4K | 27,702 | Apr 2, 2026 | Apr 6, 2026 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 2,454 | — | — | 8,904 | Nov 13, 2025 | Apr 1, 2026 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 58,230 | — | — | 58,230 | Jul 2, 2025 | Jul 7, 2025 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 19,108 | — | — | 28,012 | Jul 2, 2025 | Jul 7, 2025 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 19,108 | — | — | 28,012 | Jul 2, 2025 | Apr 1, 2026 ↗ | View → |
| PTHS PELTHOS THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 6,450 | — | — | 6,450 | Jun 14, 2024 | Apr 1, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 1,838 | $17.63 | $32.4K | 130,264 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 4,462 | $17.63 | $78.7K | 132,102 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 6,256 | — | — | 136,564 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 36,750 | — | — | 130,308 | Feb 10, 2022 | Feb 14, 2022 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 3,119 | $23.38 | $72.9K | 93,558 | Apr 1, 2021 | Apr 5, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 1,542 | $25.95 | $40.0K | 96,677 | Feb 10, 2021 | Feb 12, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 758 | $25.95 | $19.7K | 98,219 | Feb 10, 2021 | Feb 12, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 2,187 | — | — | 98,977 | Jan 19, 2021 | Jan 22, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 36,960 | — | — | 96,790 | Jan 19, 2021 | Jan 22, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 105,600 | — | — | 105,600 | Jan 19, 2021 | Jan 21, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 36,960 | — | — | 96,790 | Jan 19, 2021 | Jan 21, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 2,187 | — | — | 98,977 | Jan 19, 2021 | Jan 21, 2021 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP and Chief Medical Officer | 2,920 | $15.49 | $45.2K | 59,830 | Apr 1, 2020 | Apr 3, 2020 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 20,250 | — | — | 62,750 | Feb 5, 2020 | Feb 7, 2020 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 22,500 | — | — | 22,500 | Feb 5, 2020 | Feb 7, 2020 ↗ | View → |